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The Role of NF-kappaB
Basic and translational 
researchers Dr. Michael May 
and Dr. Nicola Mason are 
working together to evaluate 
the role of NF-kappaB in canine 
cancer development and the potential therapeutic use of 
NBD peptide in the treatment of canine cancer. 
NF-kappaB effects the regulation of genes linked to 
immune responses, differentiation, cell growth, and the 
death of cells. It is found in many solid tumors where 
it contributes to reproduction of malignant cells and 
resistance to chemotherapy of malignant cells.
This work has provided the basis for a Phase I 
clinical trial to evaluate the effects of NBD peptide on 
NF-kappaB activity in dogs with relapsed, drug-resistant 
lymphoma. Further details of the clinical trial can be 
found at http://research.vet.upenn.edu/vcic.
While this trial is specifically for canine patients with 
lymphoma, the clinical, biological and genetic similarities 
between canine lymphoma and Non-Hodgkin’s lymphoma 
(NHL) in humans indicates that findings in dogs may 
provide valuable information for humans with NHL. 
Penn Shelter Canine  
Mammary Tumor Program
A team of clinicians at the Matthew 
J. Ryan Veterinary Hospital led by 
Dr. Karin sorenmo, Dr. Michael 
Goldschmidt, Dr. David Holt 
and Dr. Michael Moyer, V’90, Rosenthal Director of 
Penn’s Shelter Medicine Program, received funding from 
Reid and Krista Buerger to study similarities between canine 
mammary tumors and breast cancer in women.
Mammary gland tumors remain the most common 
tumors in intact female dogs and represent a common cause 
of disease and premature death in dogs around the world. 
Studies have identified many similarities between canine 
mammary tumors and breast cancer in women in terms 
of epidemiology, biology, dietary risk factors and clinical 
behavior, as well as hormonal association. The development 
of mammary tumors in dogs is dependent on exposure to 
ovarian hormones and the tumor risk can be significantly 
reduced by spaying at an early age. The risk for developing 
breast cancer in women is also associated with the 
cumulative exposure to bio-available estrogens, suggesting 
that similar hormone-driven mechanisms might be linked 
with breast cancer development in both species. 
With Wise and Thoughtful Planning,  
We All Have the Power to Make History
Gifts that fund the future of Penn Veterinary Medicine
Plan a gift today that can provide for the future of Penn by including a charitable 
bequest as part of your long term planning.  It’s as easy as naming Penn Vet as a 
beneficiary of your will, retirement plan or life insurance policy.
Benefits of a Bequest Include:
Establishes a lasting legacy•	
Enables you to make a significant contribution that may otherwise not have been   •	
possible during your lifetime
 The value of the estate intention is removed from your taxable estate•	
Most importantly, it offers the satisfaction of knowing your commitment will  
truly make a difference for the future of Penn Vet.
If you have already included Penn as part 
of your estate plan, or if you would like 
information on ways to do so, contact:
Lynn Ierardi, J.D.
800.223.8236
lierardi@dev.upenn.edu
www.upenn.planyourlegacy.org
Your gift qualifies you for membership in the  
Charles Custis Harrison Society.
